Works matching IS 00126667 AND DT 2020 AND VI 80 AND IP 6

Results: 9
    1
    2

    Remimazolam: First Approval.

    Published in:
    Drugs, 2020, v. 80, n. 6, p. 625, doi. 10.1007/s40265-020-01299-8
    By:
    • Keam, Susan J.
    Publication type:
    Article
    3
    4
    5

    Delgocitinib: First Approval.

    Published in:
    Drugs, 2020, v. 80, n. 6, p. 609, doi. 10.1007/s40265-020-01291-2
    By:
    • Dhillon, Sohita
    Publication type:
    Article
    6

    Tislelizumab: First Approval.

    Published in:
    Drugs, 2020, v. 80, n. 6, p. 617, doi. 10.1007/s40265-020-01286-z
    By:
    • Lee, Arnold;
    • Keam, Susan J.
    Publication type:
    Article
    7

    Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial.

    Published in:
    Drugs, 2020, v. 80, n. 6, p. 587, doi. 10.1007/s40265-020-01285-0
    By:
    • Dharmalingam, Mala;
    • Aravind, S. R.;
    • Thacker, Hemant;
    • Paramesh, S.;
    • Mohan, Brij;
    • Chawla, Manoj;
    • Asirvatham, Arthur;
    • Goyal, Ramesh;
    • Shembalkar, Jayashri;
    • Balamurugan, R.;
    • Kadam, Pradnya;
    • Alva, Hansraj;
    • Kodgule, Rahul;
    • Tandon, Monika;
    • Vaidyanathan, Sivakumar;
    • Pendse, Amol;
    • Gaikwad, Rajesh;
    • Katare, Sagar;
    • Suryawanshi, Sachin;
    • Barkate, Hanmant
    Publication type:
    Article
    8
    9